Traws Pharma
TRAW
TRAW
9 hedge funds and large institutions have $5.71M invested in Traws Pharma in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Holders
9
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.02M | |
| 2 | +$865K | |
| 3 | +$669K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$71.3K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$26.5K |
Top Sellers
| 1 | -$68K | |
| 2 | -$36K | |
| 3 | -$24.5K | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
-$24.2K |
| 5 |
Morgan Stanley
New York
|
-$4K |